These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24648292)
21. Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody. Bing SJ; Ha D; Ahn G; Cho J; Kim A; Park SK; Yu HS; Jee Y Clin Exp Immunol; 2015 Jun; 180(3):419-31. PubMed ID: 25619397 [TBL] [Abstract][Full Text] [Related]
22. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses. Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996 [TBL] [Abstract][Full Text] [Related]
23. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213 [TBL] [Abstract][Full Text] [Related]
24. CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells? Agahozo MC; Peferoen L; Baker D; Amor S Mult Scler Relat Disord; 2016 Sep; 9():110-7. PubMed ID: 27645355 [TBL] [Abstract][Full Text] [Related]
25. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG Giralt M; Molinero A; Hidalgo J Methods Mol Biol; 2018; 1791():227-232. PubMed ID: 30006713 [TBL] [Abstract][Full Text] [Related]
26. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE). Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622 [TBL] [Abstract][Full Text] [Related]
27. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy VK; Yu M; Yin L; Kawczak JA; Johnson JM; Mathisen PM; Weinstock-Guttman B; Kinkel RP Immunol Rev; 1998 Aug; 164():93-100. PubMed ID: 9795767 [TBL] [Abstract][Full Text] [Related]
31. The role of antibodies in multiple sclerosis. Weber MS; Hemmer B; Cepok S Biochim Biophys Acta; 2011 Feb; 1812(2):239-45. PubMed ID: 20600871 [TBL] [Abstract][Full Text] [Related]
32. Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes. Cristofanilli M; Gratch D; Pagano B; McDermott K; Huang J; Jian J; Bates D; Sadiq SA Mult Scler; 2017 Nov; 23(13):1707-1715. PubMed ID: 28273770 [TBL] [Abstract][Full Text] [Related]
33. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Ziemssen T; Ziemssen F Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612 [TBL] [Abstract][Full Text] [Related]
34. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis. Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424 [TBL] [Abstract][Full Text] [Related]
35. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis. Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035 [TBL] [Abstract][Full Text] [Related]
36. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen. Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028 [TBL] [Abstract][Full Text] [Related]
37. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501 [TBL] [Abstract][Full Text] [Related]
38. NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis. Legroux L; Moratalla AC; Laurent C; Deblois G; Verstraeten SL; Arbour N Front Immunol; 2019; 10():154. PubMed ID: 30787931 [TBL] [Abstract][Full Text] [Related]
39. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130 [TBL] [Abstract][Full Text] [Related]
40. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. Aarts SA; Seijkens TT; Kusters PJ; van Tiel CM; Reiche ME; den Toom M; Beckers L; van Roomen CP; de Winther MP; Kooij G; Lutgens E J Pathol; 2019 Apr; 247(4):471-480. PubMed ID: 30471110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]